|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/4468 | |||
| A61P 17/00 | |||
| A61K 47/10 | |||
| A61K 47/16 | |||
| A61K 47/22 | |||
| A61K 31/4535 | |||
| A61K 47/14 |
| (11) | Number of the document | 2759294 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12833553.6 |
| Date of filing the European patent application | 2012-09-21 | |
| (97) | Date of publication of the European application | 2014-07-30 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2012/007599 |
| Date | 2012-09-21 |
| (87) | Number | WO 2013/042989 |
| Date | 2013-03-28 |
| (30) | Number | Date | Country code |
| 20110095787 | 2011-09-22 | KR |
| (72) |
YU, Hyun-Suk, KR
LEE, Young-Moo, KR
KIM, Hyun-Woo, KR
KIM, Hee-Sook, KR
|
| (73) |
Samyang Biopharmaceuticals Corporation,
263, Yeonji-dong Jongno-gu, Seoul 110-725,
KR
|
| (54) | Formulation for percutaneous administration containing Fentanyl and analague thereof |
| Formulation for percutaneous administration containing Fentanyl and analague thereof |